Ligand validation:3FST

MRY: MESO-ERYTHRITOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3FST_MRY_C_5321	33%	48%	0.186	0.866	0.82	1.18	-	1	4	0	100%	0.5
3FSU_MRY_C_5320	78%	44%	0.081	0.923	0.87	1.28	-	2	0	0	100%	1
5HHF_MRY_C_605	87%	46%	0.08	0.953	0.65	1.4	-	2	0	0	100%	1
5U3D_MRY_A_301	63%	47%	0.119	0.913	0.17	1.83	-	2	2	0	100%	0.84
5U5M_MRY_B_301	57%	33%	0.132	0.905	1.72	0.95	2	-	1	0	100%	0.68
5U6A_MRY_B_301	48%	34%	0.14	0.884	1.66	0.95	2	1	1	0	100%	0.71
5EUK_MRY_C_301	41%	39%	0.173	0.886	1.52	0.9	2	-	6	0	100%	0.85

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.